Loading…
Loading…
VTYX (Ventyx Biosciences, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
| MLTX | MoonLake Immunotherapeutics | $18.94 | $1.6B |
| KALV | KalVista Pharmaceuticals, Inc. | $27.00 | $1.4B |
| ABSI | Absci Corporation | $8.24 | $1.4B |
| CRVS | Corvus Pharmaceuticals, Inc. | $13.99 | $1.2B |
| OLMA | Olema Pharmaceuticals, Inc. | $11.49 | $1.0B |
| RIGL | Rigel Pharmaceuticals, Inc. | $37.80 | $699.4M |
| RGNX | REGENXBIO Inc. | $10.20 | $527.3M |
| PRTA | Prothena Corporation plc | $8.44 | $441.9M |
| VSTM | Verastem, Inc. | $5.89 | $408.3M |
| GOSS | Gossamer Bio, Inc. | $0.14 | $33.9M |